Global Viral Inactivation Market Research Report 2026(Status and Outlook)
Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses. These biological products are used for the treatment and diagnostic purposes in humans.Estimates of their viral inactivation market segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.
The global Viral Inactivation market size was estimated at USD 607.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 10.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Viral Inactivation market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Viral Inactivation market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Viral Inactivation market.
Global Viral Inactivation Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Danaher
Merck
Parker Hannifin
Sartorius
SGS
Charles River Laboratories International
Clean Cells
Rad Source Technologies
Texcell
Viral Inactivated Plasma Systems
Wuxi Pharmatech (Cayman)
Market Segmentation (by Type)
Kits and Reagents
Services
Viral Inactivation Systems and Accessories
Market Segmentation (by Application)
Blood and Blood Products
Cellular and Gene Therapy Products
Stem Cell Products
Tissue and Tissue Products
Vaccines and Therapeutics
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Viral Inactivation Market
Overview of the regional outlook of the Viral Inactivation Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Viral Inactivation Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Viral Inactivation, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Viral Inactivation market size was estimated at USD 607.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 10.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Viral Inactivation market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Viral Inactivation market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Viral Inactivation market.
Global Viral Inactivation Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Danaher
Merck
Parker Hannifin
Sartorius
SGS
Charles River Laboratories International
Clean Cells
Rad Source Technologies
Texcell
Viral Inactivated Plasma Systems
Wuxi Pharmatech (Cayman)
Market Segmentation (by Type)
Kits and Reagents
Services
Viral Inactivation Systems and Accessories
Market Segmentation (by Application)
Blood and Blood Products
Cellular and Gene Therapy Products
Stem Cell Products
Tissue and Tissue Products
Vaccines and Therapeutics
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Viral Inactivation Market
Overview of the regional outlook of the Viral Inactivation Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Viral Inactivation Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Viral Inactivation, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Viral Inactivation
1.2 Key Market Segments
1.2.1 Viral Inactivation Segment by Type
1.2.2 Viral Inactivation Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 VIRAL INACTIVATION MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 VIRAL INACTIVATION MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Viral Inactivation Product Life Cycle
3.3 Global Viral Inactivation Revenue Market Share by Company (2020-2025)
3.4 Viral Inactivation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Viral Inactivation Market Competitive Situation and Trends
3.6.1 Viral Inactivation Market Concentration Rate
3.6.2 Global 5 and 10 Largest Viral Inactivation Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 VIRAL INACTIVATION VALUE CHAIN ANALYSIS
4.1 Viral Inactivation Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF VIRAL INACTIVATION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Viral Inactivation Market Porter's Five Forces Analysis
6 VIRAL INACTIVATION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Viral Inactivation Market by Type (2020-2025)
6.3 Global Viral Inactivation Market Size Growth Rate by Type (2021-2025)
7 VIRAL INACTIVATION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Viral Inactivation Market Size (M USD) by Application (2020-2025)
7.3 Global Viral Inactivation Market Size Growth Rate by Application (2021-2025)
8 VIRAL INACTIVATION MARKET SEGMENTATION BY REGION
8.1 Global Viral Inactivation Market Size by Region
8.1.1 Global Viral Inactivation Market Size by Region
8.1.2 Global Viral Inactivation Market Size Market Share by Region
8.2 North America
8.2.1 North America Viral Inactivation Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Viral Inactivation Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Viral Inactivation Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Viral Inactivation Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Viral Inactivation Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Danaher
9.1.1 Danaher Basic Information
9.1.2 Danaher Viral Inactivation Product Overview
9.1.3 Danaher Viral Inactivation Product Market Performance
9.1.4 Danaher SWOT Analysis
9.1.5 Danaher Business Overview
9.1.6 Danaher Recent Developments
9.2 Merck
9.2.1 Merck Basic Information
9.2.2 Merck Viral Inactivation Product Overview
9.2.3 Merck Viral Inactivation Product Market Performance
9.2.4 Merck SWOT Analysis
9.2.5 Merck Business Overview
9.2.6 Merck Recent Developments
9.3 Parker Hannifin
9.3.1 Parker Hannifin Basic Information
9.3.2 Parker Hannifin Viral Inactivation Product Overview
9.3.3 Parker Hannifin Viral Inactivation Product Market Performance
9.3.4 Parker Hannifin SWOT Analysis
9.3.5 Parker Hannifin Business Overview
9.3.6 Parker Hannifin Recent Developments
9.4 Sartorius
9.4.1 Sartorius Basic Information
9.4.2 Sartorius Viral Inactivation Product Overview
9.4.3 Sartorius Viral Inactivation Product Market Performance
9.4.4 Sartorius Business Overview
9.4.5 Sartorius Recent Developments
9.5 SGS
9.5.1 SGS Basic Information
9.5.2 SGS Viral Inactivation Product Overview
9.5.3 SGS Viral Inactivation Product Market Performance
9.5.4 SGS Business Overview
9.5.5 SGS Recent Developments
9.6 Charles River Laboratories International
9.6.1 Charles River Laboratories International Basic Information
9.6.2 Charles River Laboratories International Viral Inactivation Product Overview
9.6.3 Charles River Laboratories International Viral Inactivation Product Market Performance
9.6.4 Charles River Laboratories International Business Overview
9.6.5 Charles River Laboratories International Recent Developments
9.7 Clean Cells
9.7.1 Clean Cells Basic Information
9.7.2 Clean Cells Viral Inactivation Product Overview
9.7.3 Clean Cells Viral Inactivation Product Market Performance
9.7.4 Clean Cells Business Overview
9.7.5 Clean Cells Recent Developments
9.8 Rad Source Technologies
9.8.1 Rad Source Technologies Basic Information
9.8.2 Rad Source Technologies Viral Inactivation Product Overview
9.8.3 Rad Source Technologies Viral Inactivation Product Market Performance
9.8.4 Rad Source Technologies Business Overview
9.8.5 Rad Source Technologies Recent Developments
9.9 Texcell
9.9.1 Texcell Basic Information
9.9.2 Texcell Viral Inactivation Product Overview
9.9.3 Texcell Viral Inactivation Product Market Performance
9.9.4 Texcell Business Overview
9.9.5 Texcell Recent Developments
9.10 Viral Inactivated Plasma Systems
9.10.1 Viral Inactivated Plasma Systems Basic Information
9.10.2 Viral Inactivated Plasma Systems Viral Inactivation Product Overview
9.10.3 Viral Inactivated Plasma Systems Viral Inactivation Product Market Performance
9.10.4 Viral Inactivated Plasma Systems Business Overview
9.10.5 Viral Inactivated Plasma Systems Recent Developments
9.11 Wuxi Pharmatech (Cayman)
9.11.1 Wuxi Pharmatech (Cayman) Basic Information
9.11.2 Wuxi Pharmatech (Cayman) Viral Inactivation Product Overview
9.11.3 Wuxi Pharmatech (Cayman) Viral Inactivation Product Market Performance
9.11.4 Wuxi Pharmatech (Cayman) Business Overview
9.11.5 Wuxi Pharmatech (Cayman) Recent Developments
10 VIRAL INACTIVATION MARKET FORECAST BY REGION
10.1 Global Viral Inactivation Market Size Forecast
10.2 Global Viral Inactivation Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Viral Inactivation Market Size Forecast by Country
10.2.3 Asia Pacific Viral Inactivation Market Size Forecast by Region
10.2.4 South America Viral Inactivation Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Viral Inactivation by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Viral Inactivation Market Forecast by Type (2026-2035)
11.1.1 Global Viral Inactivation Market Size Forecast by Type (2026-2035)
11.2 Global Viral Inactivation Market Forecast by Application (2026-2035)
11.2.1 Global Viral Inactivation Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Viral Inactivation
1.2 Key Market Segments
1.2.1 Viral Inactivation Segment by Type
1.2.2 Viral Inactivation Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 VIRAL INACTIVATION MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 VIRAL INACTIVATION MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Viral Inactivation Product Life Cycle
3.3 Global Viral Inactivation Revenue Market Share by Company (2020-2025)
3.4 Viral Inactivation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Viral Inactivation Market Competitive Situation and Trends
3.6.1 Viral Inactivation Market Concentration Rate
3.6.2 Global 5 and 10 Largest Viral Inactivation Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 VIRAL INACTIVATION VALUE CHAIN ANALYSIS
4.1 Viral Inactivation Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF VIRAL INACTIVATION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Viral Inactivation Market Porter's Five Forces Analysis
6 VIRAL INACTIVATION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Viral Inactivation Market by Type (2020-2025)
6.3 Global Viral Inactivation Market Size Growth Rate by Type (2021-2025)
7 VIRAL INACTIVATION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Viral Inactivation Market Size (M USD) by Application (2020-2025)
7.3 Global Viral Inactivation Market Size Growth Rate by Application (2021-2025)
8 VIRAL INACTIVATION MARKET SEGMENTATION BY REGION
8.1 Global Viral Inactivation Market Size by Region
8.1.1 Global Viral Inactivation Market Size by Region
8.1.2 Global Viral Inactivation Market Size Market Share by Region
8.2 North America
8.2.1 North America Viral Inactivation Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Viral Inactivation Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Viral Inactivation Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Viral Inactivation Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Viral Inactivation Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Danaher
9.1.1 Danaher Basic Information
9.1.2 Danaher Viral Inactivation Product Overview
9.1.3 Danaher Viral Inactivation Product Market Performance
9.1.4 Danaher SWOT Analysis
9.1.5 Danaher Business Overview
9.1.6 Danaher Recent Developments
9.2 Merck
9.2.1 Merck Basic Information
9.2.2 Merck Viral Inactivation Product Overview
9.2.3 Merck Viral Inactivation Product Market Performance
9.2.4 Merck SWOT Analysis
9.2.5 Merck Business Overview
9.2.6 Merck Recent Developments
9.3 Parker Hannifin
9.3.1 Parker Hannifin Basic Information
9.3.2 Parker Hannifin Viral Inactivation Product Overview
9.3.3 Parker Hannifin Viral Inactivation Product Market Performance
9.3.4 Parker Hannifin SWOT Analysis
9.3.5 Parker Hannifin Business Overview
9.3.6 Parker Hannifin Recent Developments
9.4 Sartorius
9.4.1 Sartorius Basic Information
9.4.2 Sartorius Viral Inactivation Product Overview
9.4.3 Sartorius Viral Inactivation Product Market Performance
9.4.4 Sartorius Business Overview
9.4.5 Sartorius Recent Developments
9.5 SGS
9.5.1 SGS Basic Information
9.5.2 SGS Viral Inactivation Product Overview
9.5.3 SGS Viral Inactivation Product Market Performance
9.5.4 SGS Business Overview
9.5.5 SGS Recent Developments
9.6 Charles River Laboratories International
9.6.1 Charles River Laboratories International Basic Information
9.6.2 Charles River Laboratories International Viral Inactivation Product Overview
9.6.3 Charles River Laboratories International Viral Inactivation Product Market Performance
9.6.4 Charles River Laboratories International Business Overview
9.6.5 Charles River Laboratories International Recent Developments
9.7 Clean Cells
9.7.1 Clean Cells Basic Information
9.7.2 Clean Cells Viral Inactivation Product Overview
9.7.3 Clean Cells Viral Inactivation Product Market Performance
9.7.4 Clean Cells Business Overview
9.7.5 Clean Cells Recent Developments
9.8 Rad Source Technologies
9.8.1 Rad Source Technologies Basic Information
9.8.2 Rad Source Technologies Viral Inactivation Product Overview
9.8.3 Rad Source Technologies Viral Inactivation Product Market Performance
9.8.4 Rad Source Technologies Business Overview
9.8.5 Rad Source Technologies Recent Developments
9.9 Texcell
9.9.1 Texcell Basic Information
9.9.2 Texcell Viral Inactivation Product Overview
9.9.3 Texcell Viral Inactivation Product Market Performance
9.9.4 Texcell Business Overview
9.9.5 Texcell Recent Developments
9.10 Viral Inactivated Plasma Systems
9.10.1 Viral Inactivated Plasma Systems Basic Information
9.10.2 Viral Inactivated Plasma Systems Viral Inactivation Product Overview
9.10.3 Viral Inactivated Plasma Systems Viral Inactivation Product Market Performance
9.10.4 Viral Inactivated Plasma Systems Business Overview
9.10.5 Viral Inactivated Plasma Systems Recent Developments
9.11 Wuxi Pharmatech (Cayman)
9.11.1 Wuxi Pharmatech (Cayman) Basic Information
9.11.2 Wuxi Pharmatech (Cayman) Viral Inactivation Product Overview
9.11.3 Wuxi Pharmatech (Cayman) Viral Inactivation Product Market Performance
9.11.4 Wuxi Pharmatech (Cayman) Business Overview
9.11.5 Wuxi Pharmatech (Cayman) Recent Developments
10 VIRAL INACTIVATION MARKET FORECAST BY REGION
10.1 Global Viral Inactivation Market Size Forecast
10.2 Global Viral Inactivation Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Viral Inactivation Market Size Forecast by Country
10.2.3 Asia Pacific Viral Inactivation Market Size Forecast by Region
10.2.4 South America Viral Inactivation Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Viral Inactivation by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Viral Inactivation Market Forecast by Type (2026-2035)
11.1.1 Global Viral Inactivation Market Size Forecast by Type (2026-2035)
11.2 Global Viral Inactivation Market Forecast by Application (2026-2035)
11.2.1 Global Viral Inactivation Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Viral Inactivation Market Size by Type (M USD)
Table 4. Global Viral Inactivation Market Size by Application
Table 5. Viral Inactivation Market Size Comparison by Region (M USD)
Table 6. Global Viral Inactivation Revenue (M USD) by Company (2020-2025)
Table 7. Global Viral Inactivation Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Inactivation as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Viral Inactivation Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Viral Inactivation Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Viral Inactivation Market Size by Type (M USD)
Table 22. Global Viral Inactivation Market Size (M USD) by Type (2020-2025)
Table 23. Global Viral Inactivation Market Share by Type (2020-2025)
Table 24. Global Viral Inactivation Market Size Growth Rate by Type (2021-2025)
Table 25. Global Viral Inactivation Market Size by Application
Table 26. Global Viral Inactivation Market Size by Application (2020-2025) & (M USD)
Table 27. Global Viral Inactivation Market Share by Application (2020-2025)
Table 28. Global Viral Inactivation Market Size Growth Rate by Application (2021-2025)
Table 29. Global Viral Inactivation Market Size by Region (2020-2025) & (M USD)
Table 30. Global Viral Inactivation Market Size Market Share by Region (2020-2025)
Table 31. North America Viral Inactivation Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Viral Inactivation Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Viral Inactivation Market Size by Region (2020-2025) & (M USD)
Table 34. South America Viral Inactivation Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Viral Inactivation Market Size by Region (2020-2025) & (M USD)
Table 36. Danaher Basic Information
Table 37. Danaher Viral Inactivation Product Overview
Table 38. Danaher Viral Inactivation Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Danaher SWOT Analysis
Table 40. Danaher Business Overview
Table 41. Danaher Recent Developments
Table 42. Merck Basic Information
Table 43. Merck Viral Inactivation Product Overview
Table 44. Merck Viral Inactivation Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Merck SWOT Analysis
Table 46. Merck Business Overview
Table 47. Merck Recent Developments
Table 48. Parker Hannifin Basic Information
Table 49. Parker Hannifin Viral Inactivation Product Overview
Table 50. Parker Hannifin Viral Inactivation Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Parker Hannifin SWOT Analysis
Table 52. Parker Hannifin Business Overview
Table 53. Parker Hannifin Recent Developments
Table 54. Sartorius Basic Information
Table 55. Sartorius Viral Inactivation Product Overview
Table 56. Sartorius Viral Inactivation Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Sartorius Business Overview
Table 58. Sartorius Recent Developments
Table 59. SGS Basic Information
Table 60. SGS Viral Inactivation Product Overview
Table 61. SGS Viral Inactivation Revenue (M USD) and Gross Margin (2020-2025)
Table 62. SGS Business Overview
Table 63. SGS Recent Developments
Table 64. Charles River Laboratories International Basic Information
Table 65. Charles River Laboratories International Viral Inactivation Product Overview
Table 66. Charles River Laboratories International Viral Inactivation Revenue (M USD) and Gross Margin (2020-2025)
Table 67. Charles River Laboratories International Business Overview
Table 68. Charles River Laboratories International Recent Developments
Table 69. Clean Cells Basic Information
Table 70. Clean Cells Viral Inactivation Product Overview
Table 71. Clean Cells Viral Inactivation Revenue (M USD) and Gross Margin (2020-2025)
Table 72. Clean Cells Business Overview
Table 73. Clean Cells Recent Developments
Table 74. Rad Source Technologies Basic Information
Table 75. Rad Source Technologies Viral Inactivation Product Overview
Table 76. Rad Source Technologies Viral Inactivation Revenue (M USD) and Gross Margin (2020-2025)
Table 77. Rad Source Technologies Business Overview
Table 78. Rad Source Technologies Recent Developments
Table 79. Texcell Basic Information
Table 80. Texcell Viral Inactivation Product Overview
Table 81. Texcell Viral Inactivation Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Texcell Business Overview
Table 83. Texcell Recent Developments
Table 84. Viral Inactivated Plasma Systems Basic Information
Table 85. Viral Inactivated Plasma Systems Viral Inactivation Product Overview
Table 86. Viral Inactivated Plasma Systems Viral Inactivation Revenue (M USD) and Gross Margin (2020-2025)
Table 87. Viral Inactivated Plasma Systems Business Overview
Table 88. Viral Inactivated Plasma Systems Recent Developments
Table 89. Wuxi Pharmatech (Cayman) Basic Information
Table 90. Wuxi Pharmatech (Cayman) Viral Inactivation Product Overview
Table 91. Wuxi Pharmatech (Cayman) Viral Inactivation Revenue (M USD) and Gross Margin (2020-2025)
Table 92. Wuxi Pharmatech (Cayman) Business Overview
Table 93. Wuxi Pharmatech (Cayman) Recent Developments
Table 94. Global Viral Inactivation Market Size Forecast by Region (2026-2035) & (M USD)
Table 95. North America Viral Inactivation Market Size Forecast by Country (2026-2035) & (M USD)
Table 96. Europe Viral Inactivation Market Size Forecast by Country (2026-2035) & (M USD)
Table 97. Asia Pacific Viral Inactivation Market Size Forecast by Region (2026-2035) & (M USD)
Table 98. South America Viral Inactivation Market Size Forecast by Country (2026-2035) & (M USD)
Table 99. Middle East and Africa Viral Inactivation Market Size Forecast by Country (2026-2035) & (M USD)
Table 100. Global Viral Inactivation Market Size Forecast by Type (2026-2035) & (M USD)
Table 101. Global Viral Inactivation Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Viral Inactivation Market Size by Type (M USD)
Table 4. Global Viral Inactivation Market Size by Application
Table 5. Viral Inactivation Market Size Comparison by Region (M USD)
Table 6. Global Viral Inactivation Revenue (M USD) by Company (2020-2025)
Table 7. Global Viral Inactivation Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Inactivation as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Viral Inactivation Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Viral Inactivation Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Viral Inactivation Market Size by Type (M USD)
Table 22. Global Viral Inactivation Market Size (M USD) by Type (2020-2025)
Table 23. Global Viral Inactivation Market Share by Type (2020-2025)
Table 24. Global Viral Inactivation Market Size Growth Rate by Type (2021-2025)
Table 25. Global Viral Inactivation Market Size by Application
Table 26. Global Viral Inactivation Market Size by Application (2020-2025) & (M USD)
Table 27. Global Viral Inactivation Market Share by Application (2020-2025)
Table 28. Global Viral Inactivation Market Size Growth Rate by Application (2021-2025)
Table 29. Global Viral Inactivation Market Size by Region (2020-2025) & (M USD)
Table 30. Global Viral Inactivation Market Size Market Share by Region (2020-2025)
Table 31. North America Viral Inactivation Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Viral Inactivation Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Viral Inactivation Market Size by Region (2020-2025) & (M USD)
Table 34. South America Viral Inactivation Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Viral Inactivation Market Size by Region (2020-2025) & (M USD)
Table 36. Danaher Basic Information
Table 37. Danaher Viral Inactivation Product Overview
Table 38. Danaher Viral Inactivation Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Danaher SWOT Analysis
Table 40. Danaher Business Overview
Table 41. Danaher Recent Developments
Table 42. Merck Basic Information
Table 43. Merck Viral Inactivation Product Overview
Table 44. Merck Viral Inactivation Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Merck SWOT Analysis
Table 46. Merck Business Overview
Table 47. Merck Recent Developments
Table 48. Parker Hannifin Basic Information
Table 49. Parker Hannifin Viral Inactivation Product Overview
Table 50. Parker Hannifin Viral Inactivation Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Parker Hannifin SWOT Analysis
Table 52. Parker Hannifin Business Overview
Table 53. Parker Hannifin Recent Developments
Table 54. Sartorius Basic Information
Table 55. Sartorius Viral Inactivation Product Overview
Table 56. Sartorius Viral Inactivation Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Sartorius Business Overview
Table 58. Sartorius Recent Developments
Table 59. SGS Basic Information
Table 60. SGS Viral Inactivation Product Overview
Table 61. SGS Viral Inactivation Revenue (M USD) and Gross Margin (2020-2025)
Table 62. SGS Business Overview
Table 63. SGS Recent Developments
Table 64. Charles River Laboratories International Basic Information
Table 65. Charles River Laboratories International Viral Inactivation Product Overview
Table 66. Charles River Laboratories International Viral Inactivation Revenue (M USD) and Gross Margin (2020-2025)
Table 67. Charles River Laboratories International Business Overview
Table 68. Charles River Laboratories International Recent Developments
Table 69. Clean Cells Basic Information
Table 70. Clean Cells Viral Inactivation Product Overview
Table 71. Clean Cells Viral Inactivation Revenue (M USD) and Gross Margin (2020-2025)
Table 72. Clean Cells Business Overview
Table 73. Clean Cells Recent Developments
Table 74. Rad Source Technologies Basic Information
Table 75. Rad Source Technologies Viral Inactivation Product Overview
Table 76. Rad Source Technologies Viral Inactivation Revenue (M USD) and Gross Margin (2020-2025)
Table 77. Rad Source Technologies Business Overview
Table 78. Rad Source Technologies Recent Developments
Table 79. Texcell Basic Information
Table 80. Texcell Viral Inactivation Product Overview
Table 81. Texcell Viral Inactivation Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Texcell Business Overview
Table 83. Texcell Recent Developments
Table 84. Viral Inactivated Plasma Systems Basic Information
Table 85. Viral Inactivated Plasma Systems Viral Inactivation Product Overview
Table 86. Viral Inactivated Plasma Systems Viral Inactivation Revenue (M USD) and Gross Margin (2020-2025)
Table 87. Viral Inactivated Plasma Systems Business Overview
Table 88. Viral Inactivated Plasma Systems Recent Developments
Table 89. Wuxi Pharmatech (Cayman) Basic Information
Table 90. Wuxi Pharmatech (Cayman) Viral Inactivation Product Overview
Table 91. Wuxi Pharmatech (Cayman) Viral Inactivation Revenue (M USD) and Gross Margin (2020-2025)
Table 92. Wuxi Pharmatech (Cayman) Business Overview
Table 93. Wuxi Pharmatech (Cayman) Recent Developments
Table 94. Global Viral Inactivation Market Size Forecast by Region (2026-2035) & (M USD)
Table 95. North America Viral Inactivation Market Size Forecast by Country (2026-2035) & (M USD)
Table 96. Europe Viral Inactivation Market Size Forecast by Country (2026-2035) & (M USD)
Table 97. Asia Pacific Viral Inactivation Market Size Forecast by Region (2026-2035) & (M USD)
Table 98. South America Viral Inactivation Market Size Forecast by Country (2026-2035) & (M USD)
Table 99. Middle East and Africa Viral Inactivation Market Size Forecast by Country (2026-2035) & (M USD)
Table 100. Global Viral Inactivation Market Size Forecast by Type (2026-2035) & (M USD)
Table 101. Global Viral Inactivation Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Industry Chain of Viral Inactivation
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Viral Inactivation Market Size (M USD), 2025-2035
Figure 5. Global Viral Inactivation Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Viral Inactivation Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Viral Inactivation Product Life Cycle
Figure 12. Global Viral Inactivation Revenue Share by Company in 2025
Figure 13. Viral Inactivation Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Viral Inactivation Revenue in 2025
Figure 15. Value Chain Map of Viral Inactivation
Figure 16. Global Viral Inactivation Market PEST Analysis
Figure 17. Global Viral Inactivation Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Viral Inactivation Market Share by Type
Figure 20. Market Share of Viral Inactivation by Type (2020-2025)
Figure 21. Global Viral Inactivation Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Viral Inactivation Market Share by Application
Figure 24. Global Viral Inactivation Market Share by Application (2020-2025)
Figure 25. Global Viral Inactivation Market Share by Application in 2024
Figure 26. Global Viral Inactivation Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Viral Inactivation Market Size Market Share by Region (2020-2025)
Figure 28. North America Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Viral Inactivation Market Size Market Share by Country in 2024
Figure 30. U.S. Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Viral Inactivation Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Viral Inactivation Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Viral Inactivation Market Share by Country in 2024
Figure 35. Germany Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Viral Inactivation Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Viral Inactivation Market Size Market Share by Region in 2024
Figure 42. China Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Viral Inactivation Market Size and Growth Rate (M USD)
Figure 48. South America Viral Inactivation Market Size Market Share by Country in 2024
Figure 49. Brazil Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Viral Inactivation Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Viral Inactivation Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Viral Inactivation Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Viral Inactivation Market Share Forecast by Type (2026-2035)
Figure 61. Global Viral Inactivation Market Share Forecast by Application (2026-2035)
Figure 1. Industry Chain of Viral Inactivation
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Viral Inactivation Market Size (M USD), 2025-2035
Figure 5. Global Viral Inactivation Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Viral Inactivation Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Viral Inactivation Product Life Cycle
Figure 12. Global Viral Inactivation Revenue Share by Company in 2025
Figure 13. Viral Inactivation Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Viral Inactivation Revenue in 2025
Figure 15. Value Chain Map of Viral Inactivation
Figure 16. Global Viral Inactivation Market PEST Analysis
Figure 17. Global Viral Inactivation Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Viral Inactivation Market Share by Type
Figure 20. Market Share of Viral Inactivation by Type (2020-2025)
Figure 21. Global Viral Inactivation Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Viral Inactivation Market Share by Application
Figure 24. Global Viral Inactivation Market Share by Application (2020-2025)
Figure 25. Global Viral Inactivation Market Share by Application in 2024
Figure 26. Global Viral Inactivation Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Viral Inactivation Market Size Market Share by Region (2020-2025)
Figure 28. North America Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Viral Inactivation Market Size Market Share by Country in 2024
Figure 30. U.S. Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Viral Inactivation Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Viral Inactivation Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Viral Inactivation Market Share by Country in 2024
Figure 35. Germany Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Viral Inactivation Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Viral Inactivation Market Size Market Share by Region in 2024
Figure 42. China Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Viral Inactivation Market Size and Growth Rate (M USD)
Figure 48. South America Viral Inactivation Market Size Market Share by Country in 2024
Figure 49. Brazil Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Viral Inactivation Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Viral Inactivation Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Viral Inactivation Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Viral Inactivation Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Viral Inactivation Market Share Forecast by Type (2026-2035)
Figure 61. Global Viral Inactivation Market Share Forecast by Application (2026-2035)
